2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Insights: "ARV-766, a PROTAC Androgen Receptor Degrader, in mCRPC - Initial Results of a Phase 1/2 Study"

107 views
June 6, 2024
Comments 0
Login to view comments. Click here to Login